I am a pediatric surgeon and a professor at the University of Cincinnati College of Medicine. I obtained my medical degree at the University of Toronto and completed my residency at Massachusetts General Hospital at Harvard Medical School. I was a Rhodes Scholar at the University of Oxford in Oxford, England, and completed a Pediatric Surgery Fellowship at the Hospital for Sick Children in Toronto, Canada. I also earned my Master of Public Health at the Harvard School of Public Health. My clinical interests are in surgical oncology and vascular anomalies.
I am currently the chair of the American Pediatric Surgical Association (APSA) Cancer Committee, the Pediatric Surgical Oncology Research Collaborative, and the Delivery of Surgical Care Committee at the American Academy of Pediatrics (AAP). I have a significant interest in Quality Improvement and serve as the American College of Surgery National Surgery Quality Improvement Program (NSQIP) Surgical Champion. Additionally, I am the surgical director of the Vascular Anomalies Clinic and the surgical director of Quality Improvement for Pediatric Surgery.
MD: University of Toronto, Toronto Canada, 1996.
Residency: Massachusetts General Hospital, Harvard Medical School 1996-2003.
Research Fellowship: University of Oxford, Oxford, England.
Fellowship: Hospital for Sick Children, Toronto, Canada.
MPH: Harvard School of Public Health, Boston, MA, 2009.
Surgical oncology; vascular malformations; minimally invasive surgery; general pediatric surgery
Colorectal Disorders, Surgery - General and Thoracic, Rare Lung Diseases, Hemangioma and Vascular Malformations
Oncology and vascular malformations
General and Thoracic Surgery
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials. Cancer. 2024; 130:3785-3796.
Contemporary surgical management of pediatric non-rhabdomyosarcoma soft tissue sarcoma. Pediatric Blood and Cancer. 2024; 71:e31257.
Central Venous Catheter Consideration in Pediatric Oncology: A Systematic Review and Meta-analysis From the American Pediatric Surgical Association Cancer Committee. Journal of Pediatric Surgery. 2024; 59:1427-1443.
Survival outcomes in pediatric patients with metastatic Ewing sarcoma who achieve a rapid complete response of pulmonary metastases. Pediatric Blood and Cancer. 2024; 71:e31026.
Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group. The Lancet Oncology. 2024; 25:912-921.
Management of undifferentiated embryonal sarcoma of the liver: A Pediatric Surgical Oncology Research Collaborative study. Pediatric Blood and Cancer. 2024; 71:e30975.
ACR Appropriateness Criteria® Soft Tissue Vascular Anomalies: Vascular Malformations and Infantile Vascular Tumors (Non-CNS)-Child. Journal of the American College of Radiology. 2024; 21:S310-S325.
Radiation dose escalation and local control for intermediate-risk rhabdomyosarcoma on ARST1431: A report from the Children’s Oncology Group. Journal of Clinical Oncology. 2024; 42:10007.
Effect of Early vs Late Inguinal Hernia Repair on Serious Adverse Event Rates in Preterm Infants: A Randomized Clinical Trial. Journal of the American Medical Association (JAMA). 2024; 331:1035-1044.
Children's Oncology Group's 2023 blueprint for research: Surgery. Pediatric Blood and Cancer. 2024; 71:e30766.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey